Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-025787
Filing Date
2021-05-10
Accepted
2021-05-10 08:23:59
Documents
9
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210510.htm 6-K 17677
2 EX-99.1 bntx-ex991_6.htm EX-99.1 1146531
3 GRAPHIC gn3pm1z5ibnt000002.jpg GRAPHIC 804
4 GRAPHIC g2yodobcb152000003.jpg GRAPHIC 6369
5 GRAPHIC g2yodobcb152000002.jpg GRAPHIC 5288062
6 GRAPHIC gn3pm1z5ibnt000004.jpg GRAPHIC 804
7 GRAPHIC g2yodobcb152000001.jpg GRAPHIC 6369
8 GRAPHIC gn3pm1z5ibnt000001.jpg GRAPHIC 804
9 GRAPHIC gn3pm1z5ibnt000003.jpg GRAPHIC 804
  Complete submission text file 0001564590-21-025787.txt   8471767
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21905348
SIC: 2836 Biological Products, (No Diagnostic Substances)